Skip to main content

JUPITER NEUROSCIENCES, INC.

For the period ended Jun 30, 2025. Filed Aug 19, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 19, 2025

JUNS$2.22+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

JUPITER NEUROSCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

June 30, 2025 · June 30, 2024
Cash Flows from Operating Activities:
Net Loss$(3,781,832)$(320,977)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on change in fair value of derivative liability-63,142
Amortization of debt discounts-9,973
Gain on extinguishment of debt-(951,868)
Gain on forgiveness of accrued compensation-(40,000)
Non- cash amortization of prepaid contracts380,182-
Shares issued for services66,000-
Stock-based compensation883,942632,300
Changes in operating assets and liabilities:
Prepaid and other current assets(60,132)-
Operating lease right of use asset(1,908)(542)
Accounts payable and accrued expenses177,48134,524
Accrued compensation442,826361,411
Increase in accrued interest2,17839,410
Net cash flows from operating activities(1,891,263)(172,627)
Cash Flows from Financing Activities:
Proceeds from note payable, related parties-109,000
Proceeds from sale of common stock-50,000
Net cash flows from financing activities-159,000
Net Change in Cash(1,891,263)(13,627)
Beginning of period3,769,51028,478
End of period$1,878,247$14,851
Supplemental disclosure of cash flow information:
Cash paid for interest$186$56,891
Cash paid for income taxes$-$-
Non-Cash Investing and Financing Activities:
Restricted stock and stock options issued for the forgiveness of accrued compensation$-$60,000
Notes payable, related party assign to Note payable$-$266,667
Receivables from Sale of Common Stock$-$75,000
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.